Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients.
Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients.
复制标题
循环 MiR-133a 作为生物标志物预测慢性血液透析患者的心脏肥大
DOI:
10.1371/journal.pone.0103079
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Yang J
中科院分区:
文献类型:
--
作者:
Wen P;Song D;Ye H;Wu X;Jiang L;Tang B;Zhou Y;Fang L;Cao H;He W;Yang Y;Dai C;Yang J
Background MicroRNAs (miRNAs) are small ribonucleotides regulating gene expression. MicroRNAs are present in the blood in a remarkably stable form and have emerged as potential diagnostic markers in patients with cardiovascular disease. Our study aimed to assess circulating miR-133a levels in MHD patients and the relation of miR-133a to cardiac hypertrophy. Methods We profiled miRNAs using RNA isolated from the plasma of participants. The results were validated in 64 MHD patients and 18 healthy controls. Results Levels of plasma miR-133a decreased in MHD patients with LVH compared with those in healthy controls. Plasma miR-133a concentrations were negatively correlated with LVMI and IVS. After single hemodialytic treatment, plasma miR-133a levels remained unchanged. Cardiac Troponin I and T were not associated with LVMI and IVS. Conclusions Our observations supplied the possibility that circulating miR-133a could be a surrogate biomarker of cardiac hypertrophy in MHD patients.
登录
查看更多内容
影响因子:
19.6
作者:
Stewart, GA;Foster, J;Jardine, AG
通讯作者:
Jardine, AG
影响因子:
--
作者:
Corsten, Maarten F.;Dennert, Robert;Schroen, Blanche
通讯作者:
Schroen, Blanche
影响因子:
13.6
作者:
Middleton, RJ;Parfrey, PS;Foley, RN
通讯作者:
Foley, RN
影响因子:
44.1
作者:
Chen, Xi;Ba, Yi;Zhang, Chen-Yu
通讯作者:
Zhang, Chen-Yu
DOI:
10.1073/pnas.0804549105
发表时间:
2008-07-29
影响因子:
11.1
作者:
Mitchell, Patrick S.;Parkin, Rachael K.;Tewari, Muneesh
通讯作者:
Tewari, Muneesh